Literature DB >> 26084021

Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.

Ari B Molofsky1, Adam K Savage2, Richard M Locksley3.   

Abstract

Interleukin-33 (IL-33) is a nuclear-associated cytokine of the IL-1 family originally described as a potent inducer of allergic type 2 immunity. IL-33 signals via the receptor ST2, which is highly expressed on group 2 innate lymphoid cells (ILC2s) and T helper 2 (Th2) cells, thus underpinning its association with helminth infection and allergic pathology. Recent studies have revealed ST2 expression on subsets of regulatory T cells, and for a role for IL-33 in tissue homeostasis and repair that suggests previously unrecognized interactions within these cellular networks. IL-33 can participate in pathologic fibrotic reactions, or, in the setting of microbial invasion, can cooperate with inflammatory cytokines to promote responses by cytotoxic NK cells, Th1 cells, and CD8(+) T cells. Here, we highlight the regulation and function of IL-33 and ST2 and review their roles in homeostasis, damage, and inflammation, suggesting a conceptual framework for future studies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26084021      PMCID: PMC4471869          DOI: 10.1016/j.immuni.2015.06.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  204 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

2.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

3.  BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.

Authors:  Anaïs Levescot; Stéphane Flamant; Sara Basbous; Florence Jacomet; Olivier Féraud; Elvire Anne Bourgeois; Marie-Laure Bonnet; Christine Giraud; Lydia Roy; Anne Barra; Jean-Claude Chomel; Ali Turhan; François Guilhot; Jean-Philippe Girard; Jean-Marc Gombert; André Herbelin
Journal:  Cancer Res       Date:  2014-03-27       Impact factor: 12.701

4.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Brown adipose tissue activity controls triglyceride clearance.

Authors:  Alexander Bartelt; Oliver T Bruns; Rudolph Reimer; Heinz Hohenberg; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Horst Weller; Christian Waurisch; Alexander Eychmüller; Philip L S M Gordts; Franz Rinninger; Karoline Bruegelmann; Barbara Freund; Peter Nielsen; Martin Merkel; Joerg Heeren
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

6.  Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

Authors:  Axel M Küchler; Jürgen Pollheimer; Johanna Balogh; Jon Sponheim; Linda Manley; Dag R Sorensen; Paula M De Angelis; Helge Scott; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

7.  Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.

Authors:  Mark D Aupperlee; Yong Zhao; Ying Siow Tan; Jeffrey R Leipprandt; Jessica Bennett; Sandra Z Haslam; Richard C Schwartz
Journal:  Endocrinology       Date:  2014-04-02       Impact factor: 4.736

8.  MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.

Authors:  Lisa A Reynolds; Yvonne Harcus; Katherine A Smith; Lauren M Webb; James P Hewitson; Ewan A Ross; Sheila Brown; Satoshi Uematsu; Shizuo Akira; David Gray; Mohini Gray; Andrew S MacDonald; Adam F Cunningham; Rick M Maizels
Journal:  J Immunol       Date:  2014-08-11       Impact factor: 5.422

9.  Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

Authors:  Emily Hams; Richard M Locksley; Andrew N J McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2013-10-28       Impact factor: 5.422

10.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  237 in total

1.  Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide α-CGRP Modulates Group 2 Innate Lymphoid Cell Responses.

Authors:  Heping Xu; Jiarui Ding; Caroline B M Porter; Antonia Wallrapp; Marcin Tabaka; Sai Ma; Shujie Fu; Xuanxuan Guo; Samantha J Riesenfeld; Chienwen Su; Danielle Dionne; Lan T Nguyen; Ariel Lefkovith; Orr Ashenberg; Patrick R Burkett; Hai Ning Shi; Orit Rozenblatt-Rosen; Daniel B Graham; Vijay K Kuchroo; Aviv Regev; Ramnik J Xavier
Journal:  Immunity       Date:  2019-10-15       Impact factor: 31.745

2.  The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation.

Authors:  Bertrand Routy; Caroline Letendre; David Enot; Maxime Chénard-Poirier; Vikram Mehraj; Noémie Charbonneau Séguin; Khaled Guenda; Kathia Gagnon; Paul-Louis Woerther; David Ghez; Silvy Lachance
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

3.  TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine.

Authors:  A Pascual-Reguant; J Bayat Sarmadi; C Baumann; R Noster; D Cirera-Salinas; C Curato; P Pelczar; S Huber; C E Zielinski; M Löhning; A E Hauser; E Esplugues
Journal:  Mucosal Immunol       Date:  2017-02-15       Impact factor: 7.313

4.  IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis.

Authors:  Jan-Hendrik Riedel; Martina Becker; Kerstin Kopp; Mathis Düster; Silke R Brix; Catherine Meyer-Schwesinger; Luis A Kluth; Ann-Christin Gnirck; Madena Attar; Sonja Krohn; Boris Fehse; Rolf A K Stahl; Ulf Panzer; Jan-Eric Turner
Journal:  J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 10.121

Review 5.  Dual oxidase: a novel therapeutic target in allergic disease.

Authors:  Albert van der Vliet; Karamatullah Danyal; David E Heppner
Journal:  Br J Pharmacol       Date:  2018-03-15       Impact factor: 8.739

6.  The emerging role of sST2 blocking in the therapy of graft-versus-host disease.

Authors:  Yifan Xiao; Fang Zheng
Journal:  Ann Transl Med       Date:  2016-10

Review 7.  The use of biologics for immune modulation in allergic disease.

Authors:  Willem van de Veen; Mübeccel Akdis
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

8.  Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33.

Authors:  T Mahlakõiv; A-L Flamar; L K Johnston; S Moriyama; G G Putzel; P J Bryce; D Artis
Journal:  Sci Immunol       Date:  2019-05-03

9.  Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.

Authors:  Hayato Nakagawa; Nobumi Suzuki; Yoshihiro Hirata; Yohko Hikiba; Yoku Hayakawa; Hiroto Kinoshita; Sozaburo Ihara; Koji Uchino; Yuji Nishikawa; Hideaki Ijichi; Motoyuki Otsuka; Junichi Arita; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Norihiro Kokudo; Keisuke Tateishi; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 10.  Tissue Immunometabolism: Development, Physiology, and Pathobiology.

Authors:  Kevin Man; Vassily I Kutyavin; Ajay Chawla
Journal:  Cell Metab       Date:  2016-09-29       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.